Bristol Myers Squibb Director Theodore Samuels Acquires Deferred Share Units
BRISTOL MYERS SQUIBB CO
Subscribe to track BMY
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
BMY | Bristol Myers Squibb Co — Form 4 Filing Insider: Theodore R. Samuels II (Director) Transaction: Acquired 821.314 Deferred Share Units @ $62.40 (~$51,250) Date: 2026-09-30 Holdings After: 71,859.041 Deferred Share Units Significance: Low (Routine Director Deferred Compensation)
Comprehensive Analysis
Bristol Myers Squibb Co ($BMY) Form 4 Summary
- Reporting Insider: Theodore R. Samuels II
- Position: Director
- Transaction Date: September 30, 2026
- Filing Date: October 2, 2026
Details
- Security: Deferred Share Units
- Transaction Code:
A(Grant/Award) - Shares Acquired: 821.314 units
- Price per Unit: $62.40
- Total Transaction Value: ~$51,250
- Post-Transaction Holdings: 71,859.041 units
Analysis
The transaction reflects a standard quarterly grant or deferral under the company's 1987 Deferred Compensation Plan for Non-Employee Directors. Each deferred share unit represents the economic equivalent of one share of common stock settleable upon cessation of board service or an elected date. Because this is an ordinary-course director compensation award rather than an open-market purchase or sale, the trading significance is rated Low.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.